Literature DB >> 2057048

The incidence of prenatal brain injury.

M Squier1, J W Keeling.   

Abstract

Recent epidemiological studies have shown that cerebral palsy is only rarely associated with birth asphyxia and that there may be more important causative factors in the prenatal period. For this reason a series of 165 brains of infants who were stillborn or died in the early neonatal period was examined in order to identify the incidence and nature of prenatal brain damage. Seventeen (44%) of the stillborn infants showed evidence of brain damage thought to be related to circulatory disorders. The most frequent abnormality, widespread ischaemic damage to the white matter of the cerebral hemispheres, occurred in 10 (26%). Criteria for white matter ischaemia were reactive astrocytosis, macrophage infiltration, karyorrhexis and endothelial swelling or reduplication. This abnormality was only seen after 27 weeks gestation. In five (13%) of the stillborn infants, haemorrhage was seen in association with ischaemic damage and in only two (5%) did brain haemorrhage occur in utero without evidence of co-existing ischaemic damage. Of the 90 live-born infants, 12 (16%) of those surviving less than 3 days and three (20%) of 15 infants who lived between 3 and 7 days after birth showed ischaemic damage which was of prenatal origin. The most frequent pathological change in the infants studied was white matter gliosis occurring in infants who survived into or beyond the last trimester. This may interfere with normal myelination by diverting glial stem cells into reactive astrocytes and thus reduce the population of oligodendrocytes available to synthesize myelin and so cause permanent neurological damage.

Entities:  

Mesh:

Year:  1991        PMID: 2057048     DOI: 10.1111/j.1365-2990.1991.tb00691.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  15 in total

Review 1.  Fetal hydrops.

Authors:  P A Boyd; J W Keeling
Journal:  J Med Genet       Date:  1992-02       Impact factor: 6.318

2.  Regional metabolic status of the E-18 rat fetal brain following transient hypoxia/ischemia.

Authors:  Svetlana Pundik; Shenandoah Robinson; W David Lust; Jennifer Zechel; Marek Buczek; Warren R Selman
Journal:  Metab Brain Dis       Date:  2006-10-20       Impact factor: 3.584

3.  Antenatal onset of haemorrhagic and/or ischaemic lesions in preterm infants: prevalence and associated obstetric variables.

Authors:  L S de Vries; P Eken; F Groenendaal; K J Rademaker; B Hoogervorst; H W Bruinse
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-01       Impact factor: 5.747

4.  Lipid peroxides are generated by the fetal rat brain after episodes of global ischemia in utero.

Authors:  S Glozman; E Yavin
Journal:  Neurochem Res       Date:  1997-02       Impact factor: 3.996

5. 

Authors:  P Dürig
Journal:  Arch Gynecol Obstet       Date:  1995-12       Impact factor: 2.344

6.  Cerebral palsy and neonatal encephalopathy.

Authors:  G Gaffney; V Flavell; A Johnson; M Squier; S Sellers
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-05       Impact factor: 5.747

7.  The Scottish perinatal neuropathology study: clinicopathological correlation in early neonatal deaths.

Authors:  J C Becher; J E Bell; J W Keeling; N McIntosh; B Wyatt
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-09       Impact factor: 5.747

8.  Changing metabolic and energy profiles in fetal, neonatal, and adult rat brain.

Authors:  W David Lust; Svetlana Pundik; Jennifer Zechel; Yinong Zhou; Marek Buczek; Warren R Selman
Journal:  Metab Brain Dis       Date:  2003-09       Impact factor: 3.584

9.  Clinical associations of prenatal ischaemic white matter injury.

Authors:  G Gaffney; M V Squier; A Johnson; V Flavell; S Sellers
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-03       Impact factor: 5.747

Review 10.  Apoptosis, oncosis, and necrosis. An overview of cell death.

Authors:  G Majno; I Joris
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.